Market research
NHP.V Lumiera Health Inc
V CAD Healthcare
Latest close
Loading market data…
Test a moving-average rule with historical data.
Market facts
- Market cap
- 850K
- P/E ratio
- Not available
- Analyst target
- Not available
- Dividend yield
- 0.0%
- Beta
- 1.97
Profile
Company facts
- Exchange
- V
- Currency
- CAD
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- ISIN
- CA5502541066
- Market cap
- 850K
- P/E ratio
- Not available
- Analyst target
- Not available
- Dividend yield
- 0.0%
- Beta
- 1.97
About
About Lumiera Health Inc
Lumiera Health Inc., together with its subsidiaries, develops and commercializes evidence-based botanical products for the healthcare in Canada. It sells oral and topical botanical agents to manage unmet medical needs; and solutions for sleep-aids and pain management. The company offers herbal tonics and supplements for cardiovascular health, stress relief, bones, joints and muscle mobility, and energy and immunity under the Holizen brand; sleep aid products under the Bazzzics brand; and pain relief cream under the Awaye brand. Lumiera Health Inc. is headquartered in Saint-Hubert, Canada.
Visit company websiteCommunity
Investor discussion
1 comment
Sign in to join the NHP.V discussion.
5 years, 5 months ago
Lumiera Health Inc is currently in a long term downtrend where the price is trading 38.2% below its 200 day moving average.
From a valuation standpoint, the stock is 99.5% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 4.6.
Lumiera Health Inc's total revenue rose by 13.1% to $145K since the same quarter in the previous year.
Its net income has dropped by 66.6% to $-1M since the same quarter in the previous year.
Finally, its free cash flow fell by 40.5% to $-200K since the same quarter in the previous year.
Based on the above factors, Lumiera Health Inc gets an overall score of 2/5.